Evidence map›Paper›PMID 41425282›Full record

ReviewFrontiers in digital health2025

Artificial intelligence in epidemic watch: revolutionizing infectious diseases surveillance.

Abdallah Borham, Lereen T Kamal, Sungsoo Chun

Abstract readReview
In one paragraph

Review in Frontiers in digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Abdallah BorhamInstitute of Global Health and Human Ecology, School of Sciences and Engineering, The American University in Cairo, New Cairo, Egypt.
Lereen T KamalInstitute of Global Health and Human Ecology, School of Sciences and Engineering, The American University in Cairo, New Cairo, Egypt.
Sungsoo ChunInstitute of Global Health and Human Ecology, School of Sciences and Engineering, The American University in Cairo, New Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence is undoubtedly emerging, and its various manifestations in technology are widely and deeply embedded in our communities. That is what obliges its mindful and skillful use and utilization, especially for infectious disease prevention. Over 1 million people are affected by infectious diseases, and the whole globe is carrying a huge burden of DALYs due to infection mortality and morbidity, which can be mitigated by the proper use of machine learning and deep learning features for data analytics and monitoring of real-time changes, and even point out the anticipated timing of pandemics. The application of machine learning and deep learning allows for forecasting and monitoring of outbreaks, which can contribute to converting the distribution of medical resources into an efficient, patient-centered approach. There are various algorithms and ML models applied in infectious disease surveillance to promote public health security. The following review considers the interface between AI and public health, with considerations of successful applications and concerns in technology acceptance and governance. Key public health policy recommendations derived from recent literature are also presented.

Indexed as

artificial intelligencedata analyticsinfectious disease surveillancemachine learningpandemicspublic health policy

Identifiers

PMID41425282
PMCPMC12711821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.